HRS-5346

N/A

Report date: 2025/10/11 10:15:09
NME

Base Information

Drug NameHRS-5346
Drug Alias NameHRS-5346HRS5346MK-7262
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApolipoprotein(a) inhibitors
TargetsApolipoprotein(a)
Therapy Area/IndicationsLipid Metabolism Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesJiangsu Hengrui Medicine Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Tuojie Biomedical Technology Co LtdMerck & Co IncBeijing Suncadia Medicine Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsLipid Metabolism Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A